(Q33863459)

29 July 2017

Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases (English)

1 reference

lysergic acid diethylamide

29 July 2017

1 reference

ChEBI release 2020-05-28

Peter Gasser

1

1 reference

29 July 2017

Dominique Holstein

2

1 reference

29 July 2017

Yvonne Michel

3

1 reference

29 July 2017

Rick Doblin

4

1 reference

29 July 2017

Berra Yazar-Klosinski

5

1 reference

29 July 2017

Torsten Passie

6

1 reference

29 July 2017

Rudolf Brenneisen

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

Journal of Nervous and Mental Disease

29 July 2017

1 reference

29 July 2017

202

1 reference

29 July 2017

7

1 reference

29 July 2017

513-520

1 reference

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

The pharmacology of lysergic acid diethylamide: a review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Long Lasting Effects of LSD on Normals

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

LSD-assisted psychotherapy with terminal cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

The effects of D-lysergic acid diethylamide on cerebral circulation and overall metabolism.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Relation of physiological and psychological effects of lysergic acid diethylamide.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

The Symptom Check-List-90-R (SCL-90-R): a German validation study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4086777

The Experimental Use of Psychedelic (LSD) Psychotherapy

29 October 2018

1 reference

12 December 2020

The effects of psychedelic (LSD) therapy on values, personality, and behavior

1 reference

12 December 2020

LSD in the supportive care of the terminally ill cancer patient

1 reference

12 December 2020

Chronic Administration of Serotonergic Antidepressants Attenuates the Subjective Effects of LSD in Humans

1 reference

12 December 2020

STUDY OF LYSERGIC ACID DIETHYLAMIDE AS AN ANALGESIC AGENT

1 reference

12 December 2020

10.1097/NMD.0000000000000113

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference